블로그

CIDP

CIDP Disease Life Expectancy: What You Should Know

Know More About CIDP Disease Life Expectancy

In general, CIDP disease life expectancy for patients is comparable to that of healthy counterparts, however, the quality of life may be significantly impacted. Quadriplegia (paralysis of the arms and legs), respiratory failure, and death rarely occur.  

전문가와 상담하세요

공제금 지원에 관하여
(877) 778-0318

Highlights

  • CIDP is a rare neurological disorder affecting nerves outside your brain and spinal cord. 
  • CIDP disease life expectancy for patients is comparable to that of their healthy counterparts.
  • Complications, coexisting medical conditions, and treatments impact life span rather than CIDP itself. 
  • Long-term outlook is generally favorable, with only a fraction of people dying due to the disease or its complications. 
  • Death rates have steadily decreased in the last few decades. 

A Quick Overview of CIDP

CIDP is a rare neurological disorder. It occurs when a person’s immune system attacks myelin (the fatty layer that protects the nerve fibers) in the peripheral nerves. Peripheral nerves lie outside your brain and spinal cord. 

About 30,000 people in the US live with CIDP [1].

How Does CIDP Affect Life Expectancy?

CIDP is unlikely to directly affect life expectancy, as evidenced in several studies. However, complications and coexisting medical issues can shorten life expectancy and cause a significant decrease in quality of life.

For instance, the risk of anxiety, depression, and memory problems is higher in people with CIDP. Weakness and fatigue can negatively impact one’s ability to perform daily activities, possibly leading to depression [2].

Additionally, there may be a higher risk of suicide among people with neurological disorders [3].

Weakness of the legs can increase the risk of falls and injuries. Moreover, people with CIDP tend to have unnoticed or repeated injuries, which can impact their life span. 

Complications may also arise due to treatment for this condition. 

Death due to CIDP is rare. Thanks to effective treatments such as IVIG and plasma exchange (plasmapheresis), deaths due to CIDP have steadily decreased from 2002 to 2014 [4]. 

Can You Recover From CIDP?

Full recovery is possible. However, permanent loss of nerve function is frequent. Moreover, the chances of functional recovery decrease with age [5].

Does CIDP Get Worse Over Time?

Early treatment is crucial to keep the symptoms under control. Without treatment, the symptoms will likely worsen. Symptoms can include:

  • Tingling or numbness in fingers and toes
  • 피로 
  • Weakness of the arms and legs
  • Loss of balance

Left untreated, 1 in 3 individuals with CIDP will need a wheelchair.

Get IVIG Copay Assistance | Your IVIG Treatment Info

IVIG 사전 승인을 받으세요
IVIG 전문가와 상담하세요

What Is the Long-term Outcome for People With CIDP?

CIDP Chronic Inflammatory Demyelinating Polyneuropathy handwritten on a blackboard.

According to a 2023 review, nearly 50% of individuals with CIDP had a favorable outcome and no disability [6].

Only a small fraction of people died due to the disease or treatment complications, and over 40% achieved remission. Remission is a period during which the signs and symptoms are reduced or no longer present.

Another study suggests that 13 – 24% of people have severe disabilities despite treatment, and about 40% of them need continuous immunosuppressant therapy [7].

In a 5-year follow-up study in Japanese CIDP patients [8]:

  • 87% of the 38 participants were able to walk 5 years later.
  • 26% experienced complete remission for over two years without treatment.
  • 39% still required immune treatments.
  • 13% had severe disabilities.

CIDP Disease Life Expectancy: Frequently Asked Questions

What is the latest treatment for CIDP?

In February 2021, the FDA approved Pfizer’s Panzyga (IVIG) for the treatment of adults with CIDP. It is the first and only FDA-approved intravenous immunoglobulin with two maintenance dosing options to treat CIDP.

Can nerves recover from CIDP?

Though permanent loss of nerve function is common, some people may have their nerve function restored.

What Is the Success Rate of CIDP Treatment?

89 – 90% of people with CIDP respond to one of the first-line therapies: IVIG, plasma exchange, and corticosteroids [9].

이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 Samantha Kaeberlein 박사, 약학박사

사만다 케버리인 약학박사는 오하이오주 캔턴에서 태어나고 자랐습니다. 2020년 노스이스트 오하이오 의과대학(NEOMED)에서 약학 학위를 받았습니다. 그녀의 직업에서 가장 보람 있는 부분은 환자들이 자신의 건강 관리에 대해 정보에 기반하고 균형 잡힌 결정을 내릴 수 있도록 의료 지침을 제공하는 것입니다. 그녀의 전문 분야는 노인 의학 및 장기 요양입니다. 여가 시간에는 야외 활동, 독서, 그리고 미국 최고의 커피를 찾는 것을 즐깁니다.

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean